As the world desperately looks for an end to the coronavirus pandemic, vaccines have turned from a distant hope to present reality and now to a frenzied, grab-what-youcan free for all. The first signs that vaccine distribution would be plagued with power imbalances came after Pfizer announced successful third phase trials for its mRNA vaccine....
Latest News:
The arms issue
What matters on Thursday, February 3
Everyone plays a waiting game
What matters on Wednesday, February 1
Six-party opposition roundtable announces the Common Policies Text
Expensive export and cheap import records were broken
What matters on Tuesday, January 31
Economic confidence on the rise
What matters on Monday, January 30
What matters on Friday, January 27
Macroprudential measures can’t replace monetary policy: TUSIAD
Digital transformation of Chinese commercial banks: OPINION
The sustainable advantages of purchasing second-hand products
It’ll be enough to manage until the election!
What matters on Wednesday, January 25
Startups receive USD 1.6bn funding in 2022
Domestic tourism expenditures skyrocket
Consumer confidence hits 16-month high
What matters on Monday, January 23
Home
covax